We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Amyloid Fibril Components Exhibit Distinct Molecular Recycling Properties

By LabMedica International staff writers
Posted on 15 Jun 2011
A publication revealed that the protein fragments comprising amyloid fibrils - abnormal strands of protein associated with some two dozen diseases ranging from Alzheimer's to type-2 diabetes – undergo a continuous cycle of dissociation and reassociation.

Previously NMR-guided simulations had shown that the two fragments, amyloid-beta-40 and amyloid-beta-42, seemed to feature highly different conformational states, with the C-terminus of amyloid-beta-42 being more structured than that of the amyloid-beta-40 fragment. More...
Now, in a paper published in the April 12, 2011, online edition of the Journal of the American Chemical Society investigators at the Institute for Research in Biomedicine (Barcelona, Spain) analyzed the movement of protein fragments within amyloid fibrils.

The investigators used an advanced technique called electrospray ionization mass spectrometry to monitor hydrogen/deuterium exchange in amyloid-beta-fibrils. They found after monitoring recycling for 40 days that both amyloid-beta-40 and amyloid-beta-42 molecules recycled within the fibril population, although to different extents. After 40 days, 80% of the molecules making up amyloid-beta-40 fibrils underwent recycling while only 30% did so in amyloid-beta-42 fibrils. These observations imply that amyloid-beta-42 recycled more slowly, which has implications for understanding the role of amyloid-beta-fibrils in neurotoxicity and for designing therapeutic strategies against Alzheimer's disease.

"In the context of Alzheimer's disease, demonstrating that recycling occurs in the fibrils is a step forward but it is also crucial to identify the recycling species involved; whether they are individual amyloid-beta units or small aggregates made of several units," said senior author Dr. Natalia Carulla, professor of chemistry at the Institute for Research in Biomedicine. "It will be important to address if differences in the recycling species within amyloid-beta-40 and amyloid-beta-42 fibrils are relevant in the development of Alzheimer's disease. We are now working towards this aim. Once we have this information, we will be in a position to devise new therapeutic strategies that can modulate recycling."

Related Links:
Institute for Research in Biomedicine


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.